| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
256,600 | 304,100 | 297,100 | 322,900 | 284,500 |
| Cost of Revenue
|
-53,000 | -86,500 | -92,300 | -128,600 | -94,900 |
|
Gross Profit
|
203,600 | 217,600 | 204,800 | 194,300 | 189,600 |
|
Selling, General and Administrative Expenses
|
-107,400 | -128,100 | -130,800 | -115,800 | -102,700 |
| Depreciation, Amortization and Depletion
|
-54,800 | -52,400 | -43,300 | -39,600 | -39,900 |
|
Operating Income/Expenses
|
-162,200 | -180,500 | -174,100 | -155,400 | -142,600 |
|
Total Operating Profit/Loss
|
41,400 | 37,100 | 30,700 | 38,900 | 47,000 |
| Total Net Finance Income/Expense
|
-39,600 | -36,400 | -28,900 | -27,000 | -24,100 |
| Net Investment Income
|
-- | -- | -- | 0 | 0 |
| Irregular Income/Expenses
|
-700 | -6,600 | 0 | 0 | 400 |
|
Non-Operating Income/Expenses, Total
|
-40,300 | -43,000 | -28,900 | -27,000 | -23,700 |
|
Pretax Income
|
1,100 | -5,900 | 1,800 | 11,900 | 23,300 |
|
Provision for Income Tax
|
-8,700 | -11,100 | 63,000 | -5,000 | -2,100 |
|
Net Income from Continuing Operations
|
-7,600 | -17,000 | 64,800 | 6,900 | 21,200 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-7,600 | -17,000 | 64,800 | 6,900 | 21,200 |
|
Net Income after Non-Controlling/Minority Interests
|
-7,600 | -17,000 | 64,800 | 6,900 | 21,200 |
|
Net Income Available to Common Stockholders
|
-7,600 | -17,000 | 64,800 | 6,900 | 21,200 |
|
Diluted Net Income Available to Common Stockholders
|
-7,600 | -17,000 | 64,800 | 6,900 | 21,200 |
| Basic EPS
|
-0.26 | -0.58 | 2.27 | 0.25 | 0.76 |
| Diluted EPS
|
-0.26 | -0.58 | 2.22 | 0.24 | 0.73 |
|
Basic Weighted Average Shares Outstanding
|
28,991.1860 | 29,060.0550 | 28,521.0270 | 28,073.4080 | 28,049.9180 |
|
Diluted Weighted Average Shares Outstanding
|
28,991.1860 | 29,060.0550 | 29,199.3750 | 29,214.5830 | 29,092.8550 |
|
Reported Normalized Diluted EPS
|
0.13 | 0.05 | 0.49 | 0.57 | 0.93 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
45,000 | 35,000 | 34,600 | 42,700 | 50,700 |
|
EBITDA
|
102,800 | 92,100 | 82,300 | 86,100 | 94,100 |
|
Normalized EBITDA
|
115,800 | 111,400 | 100,100 | 99,200 | 99,600 |
|
Normalized Income
|
2,075.9000 | 1,400 | 13,000 | 14,800 | 30,114.8000 |
|
Total Unusual Items
|
13,000 | 13,300 | 7,600 | 11,500 | 10,200 |
|
Total Unusual Items Excluding Goodwill
|
13,000 | 13,300 | 7,600 | 11,500 | 10,200 |
12/31/2022 - 12/16/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade